Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1987 Nov;40(11):1282–1286. doi: 10.1136/jcp.40.11.1282

Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease?

S A Dundas 1, R Kay 1, S Beck 1, D W Cotton 1, A J Coup 1, D N Slater 1, J C Underwood 1
PMCID: PMC1141225  PMID: 3693565

Abstract

A copy of the standardised classification (SC) proposed for assessing dysplasia in inflammatory bowel disease was circulated to six histopathologists who were asked to apply it to 40 slides from 34 patients with ulcerative colitis to test its reproducibility. The slides were relabelled and recirculated to the pathologists at least one month later. Each was asked to state whether or not key diagnostic features were present before giving a final dysplasia score for the second assessment. Only minor interobserver and intraobserver disagreements were recorded. Pathologists were most consistent at recognising back to back glands, villous mucosal architecture, hyperchromatic nuclei, stratification of nuclei, regenerative nuclei and loss of nuclear polarity. There was poor interobserver agreement in assessing dystrophic goblet cells and columnar mucous cells. Back to back glands, hyperchromatic nuclei, loss of nuclear polarity, stratification of nuclei and columnar mucous cells were considered to be the most important features for determining the severity of dysplasia. As there was poor interobserver agreement in assessing columnar mucous cells and dystrophic goblet cells these features need to be more clearly defined or should be removed from the SC.

Full text

PDF
1283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook M. G., Goligher J. C. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology. 1975 May;68(5 Pt 1):1127–1136. [PubMed] [Google Scholar]
  2. Devroede G. J., Taylor W. F., Sauer W. G., Jackman R. J., Stickler G. B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med. 1971 Jul 1;285(1):17–21. doi: 10.1056/NEJM197107012850103. [DOI] [PubMed] [Google Scholar]
  3. Dickinson R. J., Dixon M. F., Axon A. T. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet. 1980 Sep 20;2(8195 Pt 1):620–622. doi: 10.1016/s0140-6736(80)90286-x. [DOI] [PubMed] [Google Scholar]
  4. GOLDGRABER M. B., KIRSNER J. B. CARCINOMA OF THE COLON IN ULCERATIVE COLITIS. Cancer. 1964 May;17:657–665. doi: 10.1002/1097-0142(196405)17:5<657::aid-cncr2820170515>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  5. Katzka I., Brody R. S., Morris E., Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology. 1983 Jul;85(1):22–29. [PubMed] [Google Scholar]
  6. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Shove D. C., Williams C. B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977 Dec;73(6):1280–1289. [PubMed] [Google Scholar]
  7. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983 Jul 16;2(8342):149–152. doi: 10.1016/s0140-6736(83)90129-0. [DOI] [PubMed] [Google Scholar]
  8. Morson B. C., Pang L. S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967 Oct;8(5):423–434. doi: 10.1136/gut.8.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  10. Rosenstock E., Farmer R. G., Petras R., Sivak M. V., Jr, Rankin G. B., Sullivan B. H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology. 1985 Dec;89(6):1342–1346. doi: 10.1016/0016-5085(85)90653-5. [DOI] [PubMed] [Google Scholar]
  11. Thomas G. D., Dixon M. F., Smeeton N. C., Williams N. S. Observer variation in the histological grading of rectal carcinoma. J Clin Pathol. 1983 Apr;36(4):385–391. doi: 10.1136/jcp.36.4.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yardley J. H., Keren D. F. "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens. Cancer. 1974 Sep;34(3):suppl–suppl:844. doi: 10.1002/1097-0142(197409)34:3+<835::aid-cncr2820340709>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES